GlassScriptPhysician profile
Timothy J Corbin
NPI 1093881443
$491.02
in general payments reported to CMS, 2019-2025
19 companies · $147 in 2025
The $147 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $331 · 2020: $12.61 · 2025: $147.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $147.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $147.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $82.46 | 2025 | Rexulti |
| Amgen INC. | $70.41 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $34.02 | 2019 | |
| Pfizer INC. | $30.52 | 2019 | |
| Exact Sciences Corporation | $23.40 | 2025 | |
| Abbvie INC. | $23.03 | 2019 | |
| Acadia Pharmaceuticals INC | $22.24 | 2025 | Nuplazid |
| Astellas Pharma US INC | $21.47 | 2019 | |
| Genzyme Corporation | $20.66 | 2019 | |
| Cleerly, INC. | $19.05 | 2025 | Cleerly Ischemia, Cleerly Labs |
| Alexion Pharmaceuticals, INC. | $18.94 | 2019 | |
| Daiichi Sankyo INC. | $18.10 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $17.99 | 2019 | |
| Lilly USA, LLC | $17.00 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $16.89 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $16.16 | 2019 | |
| Emd Serono, INC. | $14.25 | 2019 | |
| Janssen Biotech, INC. | $12.61 | 2020 | |
| Merck Sharp & Dohme LLC | $11.82 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Corbin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.